NHS warned over new corporate killing laws:
This article was originally published in Clinica
The UK National Health Service (NHS) and other public bodies are being warned that they are unlikely to be exempt from proposed corporate killing legislation expected to be introduced during the present parliament. The warning comes from the British Safety Council, which says that four "tough laws" are set to replace the current "ineffective" law on involuntary manslaughter. The category of corporate killing aims to make companies accountable in criminal law for falling far below reasonable standards. The categories of reckless killing and killing by gross carelessness, address personal responsibility and carry prison terms of between 10 years and life. The proposed legislation comes at a time when the UK, among other countries, is seeking to introduce a blame-free culture among surgeons that commit errors (see Clinica No 966, p 7).
You may also be interested in...
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.
Sabinsa provided FDA and FTC with documentation of “an ingredient falsely marketed and sold as vitamin C derived from amla fruit (Emblica officinalis), which two independent labs have confirmed is actually derived from corn, sugarcane or other plants.”
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.